The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4)

EDITORIAL  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):285-9

SPECT/CT in oncology: the fusion of two imaging modalities is a new standard of care

Tagliabue L., Schillaci O.

PDF

FOREWORD  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):290-1

Has radio-targeting come of age? Report of the 18th IRIST meeting

Buscombe J. R., Signore A.

PDF

FOREWORD  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):292-6

Radiolabelled aptamers for tumour imaging and therapy

Perkins A. C., Missailidis S.

Abstract PDF

REVIEWS  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):297-303

Estimation of metastatic cure after radionuclide therapy

Bernhardt P., Forssell-Aronsson E.

Abstract PDF

REVIEWS  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):304-13

Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers

Albrecht H., Denardo G. L., Denardo S. J.

Abstract PDF

ORIGINAL ARTICLES  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):314-23

Evaluation of [111/114mIn]CHX-A’’-DTPA-ZHER2:342, an Affibody ligand coniugate for targeting of HER2-expressing malignant tumors

Orlova A., Rosik D., Sandström M., Lundqvist H., Einarsson L., Tolmachev V.

Abstract PDF

ORIGINAL ARTICLES  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):324-33

Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy

Melis M., Forrer F., Capello A., Bijster M., Bernard B. F., Reubi J. C., Krenning E. P., De Jong M.

Abstract PDF

ORIGINAL ARTICLES  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):334-42

Use of a 99mTc labeled anti-TNFα monoclonal antibody in Crohn’s disease: in vitro and in vivo studies

D’Alessandria C., Malviya G., Viscido A., Aratari A., Maccioni F., Amato A., Scopinaro F., Caprilli R., Signore A.

Abstract PDF

ORIGINAL ARTICLES  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):343-51

S-factor calculations for mouse models using Monte-Carlo simulations

Bitar A., Lisbona A., Bardiès M.

Abstract PDF

ORIGINAL ARTICLES  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):352-6

Iodine-123-interleukin-2 scintigraphy in metastatic hypernephroma: a pilot study

Renard V., Staelens L., Signore A., Van Belle S., Dierckx R. A., Van De Wiele C.

Abstract PDF

ORIGINAL ARTICLES  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):357-63

99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer’s disease

Nobili F., Koulibaly P. M., Rodriguez G., Benoit M., Girtler N., Robert P. H., Brugnolo A., Darcourt J.

Abstract PDF

ORIGINAL ARTICLES  ADVANCES IN RADIOIMMUNOIMAGING AND RADIOIMMUNOTHERAPY

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 December;51(4):364-71

Sensitivity of [99mTc]methoxyisobutylisonitrile scan in patients with metastatic differentiated thyroid cancer

Ronga G., Ventroni G., Montesano T., Filesi M., Ciancamerla M., Di Nicola A. D., Travascio L., Vestri A. R., Signore A.

Abstract PDF